Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.
Also called NCT03153137
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 142 participants
- Sponsor
- Registry
-
NCT03153137 -
2016-003320-23
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, China, Czechia, Denmark, France, Germany, New Zealand, Poland, Taiwan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03153137. Randomized; quadruple masking; primary purpose treatment. Start 2017-08-14 (actual); primary completion 2021-06-30 (actual). Results posted on 2022-09-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects
- Acronym
- RUBATO
- Condition
- Congenital Heart Disease
- Intervention (Drug)
- Macitentan 10 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct03153137- Content hash
cf6c166901925285ae73bf14d7b8d22f034085ee7c0122cdf403726ab147f274